Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19), a Randomized Open-label Clinical Trial

NCT05398965 is registered in ClinicalTrials.gov with Hasanuddin University as lead sponsor.

NCT NCT05398965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05398965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19), a Randomized Open-label Clinical Trial
Lead sponsor
Hasanuddin University
Phase
Phase 2
Overall status
Completed
Start date
November 18, 2020
Completion date
March 1, 2022
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19